(Reuters) -Biogen Inc is pinning its hopes on a decision on U.S. government coverage of its Alzheimer’s disease drug next year to help drive up its usage, after a big miss on quarterly sales of the much-awaited treatment.FILE PHOTO: A…
Read MoreEli Lilly bets on Alzheimer's disease drug data as it chases Biogen
(Reuters) -Eli Lilly and Co said on Tuesday it plans to seek U.S. approval for its experimental Alzheimer’s disease drug by year end and believes the treatment could be favored by doctors once it becomes available to patients.FILE PHOTO: An…
Read MoreNovavax expects COVID-19 vaccine U.S. data from trial in Q2
FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo(Reuters) – Novavax Inc said on Monday it expects to report U.S. data from a late-stage study…
Read MorePfizer sees robust COVID-19 vaccine demand for years, $26 billion in 2021 sales
(Reuters) -Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years…
Read MoreJ&J stands ready to roll out COVID-19 vaccine in Europe as regulators weigh risks
(Reuters) -Johnson & Johnson said on Tuesday it stands ready to resume rolling out its COVID-19 vaccine in Europe, where the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.FILE…
Read MoreThis Guy Did 10,000 Pushups in 30 Days and Recorded the Results
Stan Browney—or just “Browney” as he’s known to his one million subscribers on YouTube—is no stranger to a pushup challenge, whether he’s trying to set a world record for “magic” pushups or attempting to pull off a “floating” pushup that…
Read MoreVerrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)
WEST CHESTER, Pa., November 10, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced positive topline results from its Phase 2 CARE-1 clinical study of…
Read MoreTime to Results Faster With Point-of-Care COVID-19 Testing
THURSDAY, Oct. 15, 2020 — Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19, according to a study published online Oct. 8 in The Lancet Respiratory Medicine. Nathan J. Brendish, Ph.D.,…
Read MoreCOVID-19 rapid test has successful lab results, research moves to next stages
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra…
Read MoreSimpler COVID-19 test could provide results in hours from saliva
Volunteers at four sites in Madison are being tested for the virus that causes COVID-19 by spitting in a vial, which may prove faster, cheaper and less complicated than other common tests, according to University of Wisconsin–Madison researchers. Scientists from…
Read More